全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Optimal Postoperative Treatment for Composite Laryngeal Small Cell Carcinoma

DOI: 10.1155/2013/806284

Full-Text   Cite this paper   Add to My Lib

Abstract:

Small cell carcinoma (SmCC) most commonly occurs in the lung and rarely arises from the head and neck region. Further, composite SmCC is extremely rare. Therefore, no postoperative treatment strategy has been established. We report a 59-year-old male patient referred to our outpatient clinic for further examination and treatment of a laryngeal tumor. Biopsy from the tumor revealed squamous cell carcinoma (SCC). The preoperative diagnosis was supraglottic SCC (T3N2bM0), and total laryngectomy and bilateral neck dissection were performed. Pathological examination revealed 2 individual cancer components: SmCC and SCC. Postoperative chemoradiotherapy (2 courses of cisplatin (CDDP) and etoposide (VP-16)) was indicated. Following the postoperative chemoradiotherapy, 2 courses of adjuvant chemotherapy were administered. The patient is currently alive with no evidence of disease at 36 months following the completion of therapy. Postoperative chemoradiotherapy and adjuvant chemotherapy are optimal treatment strategies for laryngeal composite SmCC. 1. Introduction Small cell carcinoma (SmCC) most commonly occurs in the lung and rarely arises from the head and neck region. SmCC combined with another carcinoma is classified as combined or composite SmCC and is extremely rare. SmCC arising in the larynx accounts for only 0.5% of all laryngeal cancers, and composite SmCC arising in the larynx accounts for less than 10% of laryngeal SmCC [1]. Therefore, clinical experiences are very limited. The standard treatment for laryngeal and laryngeal composite SmCC is chemotherapy and radiotherapy [2–4]. However, it is difficult to diagnose laryngeal composite SmCC before an operation [5]. For these patients, systemic postoperative treatment is essential. However, no postoperative treatment strategy for composite SmCC in the head and neck region has been established. Here, we present a case of laryngeal composite SmCC and discuss the optimal postoperative treatment. 2. Case Presentation A 59-year-old male patient was referred to our outpatient clinic for further examination and treatment of a laryngeal tumor. The patient had no remarkable medical or family history, was a heavy smoker (60 pack-years), and was a social drinker. The tumor was detected at the left arytenoid, and the left vocal cord was fixed (Figure 1). A computed tomography (CT) scan showed that the thyroid cartilage was intact. Several cervical lymph node metastases were detected on the left side of the neck; however, distant metastasis was not detected. Cervical ultrasonography also revealed multiple metastatic

References

[1]  L. Barnes, “Neuroendocrine tumours,” in WHO Classification of Tumours, Pathology and Genetics, Head and Neck Tumours, pp. 135–139, 2004.
[2]  A. Ferlito, C. E. Silver, C. R. Bradford, and A. Rinaldo, “Neuroendocrine neoplasms of the larynx: an overview,” Head and Neck, vol. 31, no. 12, pp. 1634–1646, 2009.
[3]  J. L. Barker Jr., B. S. Glisson, A. S. Garden et al., “Management of nonsinonasal neuroendocrine carcinomas of the head and neck,” Cancer, vol. 98, no. 11, pp. 2322–2328, 2003.
[4]  A. Barbeaux, L. Duck, J.-F. Baurain et al., “Primary combined squamous and small cell carcinoma of the larynx: report of two cases and discussion of treatment modalities,” European Archives of Oto-Rhino-Laryngology and Head & Neck, vol. 263, no. 8, pp. 786–790, 2006.
[5]  G. Aggarwal, L. Jackson, and S. Sharma, “Primary combined small cell carcinoma of larynx with lateralized histologic components and corresponding sidespecific neck nodal metastasis: report of a unique case and review of literature,” International Journal of Clinical and Experimental Pathology, vol. 4, no. 1, pp. 111–117, 2011.
[6]  D. R. Gnepp, “Small cell neuroendocrine carcinoma of the larynx. A critical review of the literature,” ORL, vol. 53, no. 4, pp. 210–219, 1991.
[7]  V. Chandra, M. S. Allen, F. C. Nichols III, C. Deschamps, S. D. Cassivi, and P. C. Pairolero, “The role of pulmonary resection in small cell lung cancer,” Mayo Clinic Proceedings, vol. 81, no. 5, pp. 619–624, 2006.
[8]  J.-P. Pignon, R. Arriagada, D. C. Ihde et al., “A meta-analysis of thoracic radiotherapy for small-cell lung cancer,” The New England Journal of Medicine, vol. 327, no. 23, pp. 1618–1624, 1992.
[9]  NCCN Clinical Practice Guideline In Oncology Lung Cancers version1. 2012, http://www.nccn.org/.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133